News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Valuable insights from a new article on Unresectable Stage IIIA/IIIB NSCLC – IU Simon Comprehensive Cancer Center
IU Simon Comprehensive Cancer Center/LinkedIn
Jan 7, 2025, 14:28

Valuable insights from a new article on Unresectable Stage IIIA/IIIB NSCLC – IU Simon Comprehensive Cancer Center

IU Simon Comprehensive Cancer Center shared a post on LinkedIn about a recent paper by Michael Weisman et al. published in International Journal of Radiation Oncology, Biology, Physics:

“Evaluation of Radiation Pneumonitis in a Phase 2 Study of Consolidation Immunotherapy With Nivolumab and Ipilimumab or Nivolumab Alone Following Concurrent Chemoradiation Therapy for Unresectable Stage IIIA/IIIB Non-Small Cell Lung Cancer”

Authors: Michael Weisman, Greg Durm, Misty Dawn Shields, Nasser Hanna, Sandra Althouse, Tim Lautenschlaeger.

Valuable insights from a new article on Unresectable Stage IIIA/IIIB NSCLC - IU Simon Comprehensive Cancer Center

“Gain valuable insights from a new article published in the International Journal of Radiation Oncology, Biology, Physics by the cancer center’s Greg Durm, MD, Misty D. Shields, MD, PhD, Nasser H. Hanna, MD, Tim Lautenschlaeger, MD, and colleagues.”

More posts featuring IU Simon Comprehensive Cancer Center.

cancer Greg Durm ipilimumab IU Simon Comprehensive Cancer Center Michael Weisman Misty Dawn Shields Nasser Hanna nivolumab non small cell lung cancer NSCLC OncoDaily Oncology Sandra Althouse Tim Lautenschlaeger
Special Coverage
Science
Jan 7, 2025, 14:28
Valuable insights from a new article on Unresectable Stage IIIA/IIIB NSCLC - IU Simon Comprehensive Cancer Center
Insight
Jan 7, 2025, 14:24
Mark Lythgoe: FDA Approves Subcutaneous Nivolumab and Atezolizumab - Boosting Immunotherapy Access
Science
Jan 7, 2025, 14:23
Bridging the gap between Radiotherapy and mHSPC - Andrea Lancia
Blog
Jan 7, 2025, 14:21
Shahrin Ahmed: Squamous cell carcinoma can be prevented long-term with the help of new immunotherapy
Blog
Jan 7, 2025, 14:18
ctDNA and Beyond to Serve Immunotherapy Key Insights from ESMOImmuno24 - International Society of Liquid Biopsy
Dialogues
Jan 7, 2025, 14:13
Beyond the Cancer Diagnosis: Dialogue with Emanuela Dodeva, by Adrian Pogacian
Insight
Jan 7, 2025, 14:09
Merit Elmaadawy: Excited for the Radiology course at the 17th BGICC
Science
Jan 7, 2025, 13:39
Myeloma Paper of the Day, January 7th, suggested by Robert Orlowski
Insight
Jan 7, 2025, 13:33
5 papers about Lung Cancer suggested by Stephen Liu
Career
Jan 7, 2025, 13:30
Asim Belgaumi has been appointed as the Director for the St. Jude Global Eastern Mediterranean Regional Hub
Insight
Jan 7, 2025, 13:16
The agenda for the 2025 CACA-OncoDaily-SPCC Cancer Summit: Bridging Continents
Blog
Jan 7, 2025, 13:15
Douglas Flora: Launching The Augmented Oncologist on Substack